David Ashley, MBBS, FRACP, PhD, To Become Director Of Pediatric Neuro-Oncology

David Ashley, MBBS, FRACP, PhD, will step down from his roles as Chair of Medicine and Director of the Andrew Love Cancer Center at Deakin University in Australia to assume a new leadership position at Duke as Director of Pediatric Neuro-Oncology. Ashley is internationally considered a top figure in pediatric brain tumor research. He has contributed hundreds of publications to the academic medical arena, received numerous highly sought-after grants, and held several distinguished leadership roles.

Ashley's arrival at Duke in the beginning of July will be a turning point for The Preston Robert Tisch Brain Tumor Center's Pediatric Neuro-Oncology Program. Pediatric brain tumors remain difficult to treat, and are now the number one cancer-killer in children. The Preston Robert Tisch Brain Tumor Center will not stand for this, and neither will Ashley. His expertise in epigenetic therapies and immunotherapies, his collaboration with other brilliant scientists at Duke, and his passion for helping children are all powerful weapons with the potential to end this war on brain cancer!